Remove 2050 Remove Cultivation Remove Oil Remove Programs
article thumbnail

Weekly Legislative Roundup 2/22/20

NORML

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. It would not allow patients to smoke herbal marijuana or vape, but would allow forms including pills, oils, lozenges and patches.

article thumbnail

Leafreport….”CBD Pricing Report: The Price Difference between the Cheapest and Most Expensive Topicals Increases to 11142%”

Cannabis Law Report

In the midst of a largely unregulated market, however, it can be challenging to separate snake oil from high-quality, reputable products. Difference between highest and lowest product prices: 2050%. Mitch Meyers, co-founder BeLeaf Life Oils , also emphasizes that you get what you pay for. Isolate tinctures. Pet edibles.

Topical 97
article thumbnail

Further Consideration of the STATES Act

Cannabis Law Report

In the Controlled Substances Act, Congress has generally prohibited the cultivation, distribution, and possession of marijuana. 2050 , 2051, 2075; Pub. Attorney General Jeff Sessions summarized the Controlled Substances Act (CSA) as it relates to cannabis and the other crimes that may be triggered by violating the CSA. 2 1 U.S.C. §

Banking 45